76 related articles for article (PubMed ID: 10191700)
1. Comparison of haemostatic parameters in arterial and venous blood from patients with peripheral arterial occlusive disease.
Woller T; Lawall H; Amann B; Angelkort B
Vasa; 1999 Feb; 28(1):10-4. PubMed ID: 10191700
[TBL] [Abstract][Full Text] [Related]
2. Thrombin-antithrombin complex and the prothrombin fragment in arterial and venous blood of patients with peripheral arterial disease.
Hering J; Amann B; Angelkort B; Rottmann M
Vasa; 2003 Nov; 32(4):193-7. PubMed ID: 14694767
[TBL] [Abstract][Full Text] [Related]
3. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
4. Comparison of markers of coagulation activation and thrombin generation test in uncomplicated pregnancies.
Joly B; Barbay V; Borg JY; Le Cam-Duchez V
Thromb Res; 2013 Sep; 132(3):386-91. PubMed ID: 23962423
[TBL] [Abstract][Full Text] [Related]
5. Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease.
De Buyzere M; Philippé J; Duprez D; Baele G; Clement DL
Am J Hematol; 1993 Jun; 43(2):91-4. PubMed ID: 8342557
[TBL] [Abstract][Full Text] [Related]
6. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
7. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.
Renner W; Köppel H; Brodmann M; Pabst E; Schallmoser K; Toplak H; Wascher TC; Pilger E
Thromb Haemost; 2000 Jan; 83(1):20-2. PubMed ID: 10669148
[TBL] [Abstract][Full Text] [Related]
8. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease.
Poredos P; Stegnar M; Gacnik A
Vasa; 1999 May; 28(2):106-11. PubMed ID: 10409921
[TBL] [Abstract][Full Text] [Related]
9. Procoagulant activity in patients with sickle cell trait.
Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
[TBL] [Abstract][Full Text] [Related]
10. Plasma thrombin-antithrombin complex, prothrombin fragments 1 and 2, and D-dimer levels are elevated after endovascular but not open repair of infrarenal abdominal aortic aneurysm.
Bailey MA; Griffin KJ; Sohrabi S; Whalley DJ; Johnson AB; Baxter PD; Ariëns RA; Scott DJ
J Vasc Surg; 2013 Jun; 57(6):1512-8. PubMed ID: 23490299
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
[TBL] [Abstract][Full Text] [Related]
12. Hemostasis activation in thrombophilic subjects with or without a history of venous thrombosis.
Cuderman TV; Bozic M; Peternel P; Stegnar M
Clin Appl Thromb Hemost; 2008 Jan; 14(1):55-62. PubMed ID: 17895509
[TBL] [Abstract][Full Text] [Related]
13. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation and fibrinolysis activation during sudden arterial occlusion of lower extremities--an association with ischemia and patient outcome.
Peltonen S; Lassila R; Rossi P; Salenius JP; Lepäntalo M
Thromb Haemost; 1995 Dec; 74(6):1442-6. PubMed ID: 8772217
[TBL] [Abstract][Full Text] [Related]
15. [Activation of hemostasis in patients with chronic cholecystitis].
Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
[TBL] [Abstract][Full Text] [Related]
16. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolysis in chronic venous insufficiency.
Blomgren L; Johansson G; Siegbahn A; Bergqvist D
Vasa; 2001 Jul; 30(3):184-7. PubMed ID: 11582948
[TBL] [Abstract][Full Text] [Related]
18. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
19. Increased left atrial thrombin generation in mitral stenosis is not reflected in arterial prothrombin fragment 1+2 levels.
Peverill RE; Harper RW; Gan TE; Smolich JJ
Clin Sci (Lond); 2000 Apr; 98(4):501-6. PubMed ID: 10731487
[TBL] [Abstract][Full Text] [Related]
20. [Thrombin generation test].
Espitia O; Fouassier M
Rev Med Interne; 2015 Oct; 36(10):690-3. PubMed ID: 26028157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
